Chesapeake Wealth Management Astrazeneca PLC Transaction History

Chesapeake Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$48.42 - $60.18 $195,132 - $242,525	-4,030 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$47.16 - $54.44 $107,807 - $124,449	-2,286 Reduced 36.19%	4,030 $200,000
Q4 2020 Feb 05, 2021	SELL	$48.52 - $58.02 $253,808 - $303,502	-5,231 Reduced 45.3%	6,316 $315,000
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $76,420 - $87,984	1,440 Added 14.25%	11,547 $633,000
Q2 2020 Aug 11, 2020	BUY	$43.1 - $55.31 $181,882 - $233,408	4,220 Added 71.68%	10,107 $535,000
Q1 2020 Apr 29, 2020	BUY	$37.79 - $51.33 $222,469 - $302,179	5,887 New	5,887 $263,000

1,336

477M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $220B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Chesapeake Wealth Management with notifications on news.